HEADACHE REMEDIES; ANTACIDS; LAXATIVES; FIRST AID TREATMENT; ADHESIVE BANDAGES

Published on .

Rank Dollar sales to date Market share

'94 '93 Brand 1994 % chg 1994 1993

1 1 Tylenol $581.5 5.4 26.3 26.2

2 2 private label 432.4 14.1 19.6 18.0

3 3 Advil 319.4 6.8 14.5 14.2

4 6 Tylenol PM 94.4 22.0 4.3 3.7

5 4 Excedrin 94.3 9.1 4.3 4.1

6 5 Motrin IB 88.3 8.6 4.0 3.9

7 7 Genuine Bayer67.0 -3.2 3.0 3.3

8 8 Children's Tylenol64.5 -2.3 2.9 3.1

9 9 Anacin 53.2 -8.7 2.4 2.8

10 11 Excedrin PM 45.0 -3.6 2.0 2.2

Total headache remedies 2,207.7 4.9 100.0 100.0

Dollars are in millions for 52 weeks ended July 2, 1994. Strong growth by Johnson & Johnson's Tylenol PM combined with gains by the main brand to help Tylenol's franchise gain a half share point. But the real headache for brand marketers is the boom in sales of private label aspirin, acetaminophen and ibuprofen.

Rank Dollar sales to date Market share

'94 '93 Brand 1994 % chg 1994 1993

1 1 Mylanta $137.4 5.0 18.9 18.5

2 2 Pepto-Bismol 102.1 -0.8 14.1 14.5

3 4 Tums 85.0 11.9 11.7 10.7

4 3 Rolaids 83.4 -3.2 11.5 12.1

5 6 private label 66.8 15.7 9.2 8.1

6 5 Maalox Plus 63.4 -8.8 8.7 9.8

7 7 Tums E-X 62.7 12.2 8.6 7.9

8 8 Maalox 30.7 -4.0 4.2 4.5

9 9 Gaviscon 28.8 2.4 4.0 4.0

10 11 Emetrol 12.1 5.6 1.7 1.6

Total antacids 725.6 2.3 100.0 100.0

Dollars are in millions for 52 weeks ended July 2, 1994. Tum-ta-tum-tum: SmithKline Beecham's Tums staged a major assault on rivals last year, gaining nearly 2 share points against rivals J&J's Mylanta, Rorer Pharmaceuticals' Maalox and Warner-Lambert's Rolaids. Brand new on shelves this summer: Tums Ultra.

Rank Dollar sales to date Market share

'94 '93 Brand 1994 % chg 1994 1993

1 1 Metamucil $149.8 -3.6 21.8 23.4

2 2 private label 141.2 9.7 20.6 19.3

3 3 Correctol 45.6 -3.8 6.6 7.1

4 4 Ex-Lax 43.1 -5.9 6.3 6.9

5 5 Phillips' 40.5 -4.8 5.9 6.4

6 6 Fibercon 33.4 13.5 4.9 4.4

7 7 Dulcolax 26.5 3.0 3.9 3.9

8 9 Citrucel 25.2 26.0 3.7 3.0

9 8 Perdiem 21.8 7.8 3.2 3.0

10 10 Senokot 19.5 12.0 2.8 2.6

Total laxatives 685.9 3.1 100.0 100.0

Dollars are in millions for 52 weeks ended July 2, 1994. Marion Merrell Dow's Citrucel, promising a smoother taste than P&G's category standard, Metamucil, posted impressive gains, as did American Cyanamid's Fibercon. Although Metamucil continues the undisputed No. 1 brand, looming right behind P&G are store brands.

Rank Dollar sales to date Market share

'94 '93 Brand 1994 % chg 1994 1993

1 1 Nix $25.5 13.8 11.1 10.4

2 2 Benadryl 23.9 17.2 10.5 9.5

3 3 Rid 20.0 10.0 8.8 8.4

4 4 private label 16.2 -1.1 7.1 7.6

5 6 Dr. Scholl's Clear Away 11.9 7.9 5.2 5.1

6 5 Lanacane 10.2 -9.7 4.4 5.2

7 12 Johnson & Johnson 8.6 22.0 3.7 3.2

8 8 Compound W 8.0 -1.7 3.5 3.7

9 11 Bactine 7.8 7.9 3.4 3.4

10 9 Campho-Phenique 7.8 -3.4 3.4 3.7

Total first aid treatments 228.8 5.9 100.0 100.0

Dollars are in millions for 52 weeks ended July 2, 1994. Delousing products Nix, from Burroughs-Wellcome Co., and Pfizer's Rid took in more than $5 million in additional sales last year, outpacing category growth. Miles' standby Bactine posted growth again, and J&J's kid-targeted treatments grew its share.

Rank Dollar sales to date Market share

'94 '93 Brand 1994 % chg 1994 1993

1 1 Band-Aid $117.2 9.6 53.9 54.1

2 2 Curad 40.3 -2.5 18.5 20.9

3 3 private label 34.9 10.9 16.0 15.9

4 50 3M Active Strips 6.3 0.0 2.9 0.0

5 7 Star Strips 5.1 93.6 2.3 1.3

6 5 Curity Telfa 4.5 2.6 2.1 2.2

7 4 Mickey & Pals 4.3 -12.3 2.0 2.5

8 6 Kid Care 2.4 -40.7 1.1 2.0

9 11 Bioclusive 0.3 11.4 0.1 0.1

10 10 White Cross 0.3 -13.8 0.1 0.1

Total adhesive bandages 217.7 10.1 100.0 100.0

Dollars are in millions for 52 weeks ended July 2, 1994. Adhesive bandages with new features-designs for kids, clear tape for adults and flexible fabrics for hard-to-tape places-obviously are sticking, and boosting category sales. J&J's Band-Aid controls more than half the market, with Kendall-Futuro's Curad a distant second.

In this article:
Most Popular